Filings & corporate actions
- 30 OctresultsResults · Q2 FY27 · consolidated and standalone+1.4%NSE
- 13 OctshareholdingShareholding · 30 Sept 2026-2.1%NSE
- 5 AugdividendDividend · ₹32.00 per share-2.5%
- 30 JulresultsResults · Q1 FY27 · consolidated and standalone+0.8%NSE
- 14 JulshareholdingShareholding · 30 Jun 2026-0.4%NSE
- 5 MayresultsResults · Q4 FY26 · consolidated and standalone+6.9%NSE
- 13 AprshareholdingShareholding · 31 Mar 2026+3.3%NSE
- 30 JanresultsResults · Q3 FY26 · consolidated and standalone+0.9%NSE
- 12 JanshareholdingShareholding · 31 Dec 2025-1.3%NSE
Reaction to results · all yearsrose on day 0 in 52 of 79 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q2 FY27 | 30 Oct 2026 | +1.4% | -4.4% | — | 9.7× |
| Q1 FY27 | 30 Jul 2026 | +0.8% | +1.5% | +3.5% | 1.9× |
| Q4 FY26 | 5 May 2026 | +6.9% | +7.8% | +1.7% | 9.3× |
| Q3 FY26 | 30 Jan 2026 | +0.9% | +2.5% | +7.6% | 0.3× |
| Q2 FY26 | 3 Nov 2025 | +2.8% | +1.1% | +2.7% | 2.8× |
| Q1 FY26 | 28 Jul 2025 | +2.0% | -4.7% | -9.4% | 0.7× |
| Q4 FY25 | 30 Apr 2025 | -4.5% | -6.2% | -7.2% | 1.7× |
| Q3 FY25 | 30 Jan 2025 | +0.7% | +0.8% | -7.1% | 2.5× |
| Q2 FY25 | 29 Oct 2024 | +0.1% | +6.5% | +0.3% | 0.8× |
| Q1 FY25 | 30 Jul 2024 | +6.5% | +16.2% | +24.5% | 4.8× |
| Q4 FY24 | 2 May 2024 | +6.7% | +6.4% | +4.4% | 29.2× |
| Q3 FY24 | 31 Jan 2024 | +0.3% | +1.3% | +1.6% | 4.8× |
| Q2 FY24 | 31 Oct 2023 | +3.6% | +2.2% | +12.1% | 3.7× |
| Q1 FY24 | 27 Jul 2023 | +4.1% | +12.5% | +11.1% | 17.4× |
| Q4 FY23 | 5 May 2023 | -1.5% | -2.1% | +6.2% | 2.9× |
| Q3 FY23 | 2 Feb 2023 | +0.3% | +1.6% | -1.4% | 1.4× |
| Q2 FY23 | 4 Nov 2022 | -0.8% | +1.9% | -1.7% | 0.9× |
| Q1 FY23 | 29 Jul 2022 | +0.5% | +0.6% | +7.7% | 2.4× |
| Q4 FY22 | 11 May 2022 | +3.1% | +2.9% | +6.9% | 1.1× |
| Q3 FY22 | 31 Jan 2022 | -1.1% | -3.9% | -20.8% | 0.7× |
| Q2 FY22 | 1 Nov 2021 | +4.2% | +1.6% | -1.9% | 1.7× |
| Q1 FY22 | 30 Jul 2021 | -4.3% | -4.1% | -6.8% | 2.1× |
| Q4 FY21 | 1 May 2021 | -0.2% | +9.2% | +5.1% | 1.5× |
| Q3 FY21 | 3 Feb 2021 | +3.1% | +2.5% | 0.0% | 7.3× |
| Q2 FY21 | 4 Nov 2020 | +0.3% | -3.6% | -0.9% | 4.7× |
| Q1 FY21 | 31 Jul 2020 | +7.7% | +12.0% | +3.8% | 6.1× |
| Q4 FY20 | 21 May 2020 | +3.4% | +5.9% | +0.9% | 5.8× |
| Q3 FY20 | 6 Feb 2020 | +8.9% | +21.5% | +21.4% | 6.6× |
| Q2 FY20 | 6 Nov 2019 | +1.0% | -2.7% | -2.5% | 3.3× |
| Q1 FY20 | 1 Aug 2019 | +8.4% | +8.2% | +15.6% | 8.1× |
| Q4 FY19 | 8 May 2019 | +0.6% | -2.0% | -5.3% | 0.4× |
| Q3 FY19 | 1 Mar 2019 | +0.8% | +0.7% | +5.5% | 0.7× |
| Q2 FY19 | 21 Nov 2018 | -3.5% | +1.8% | -1.4% | 0.7× |
| Q1 FY19 | 7 Aug 2018 | +4.3% | +4.4% | +11.8% | 1.1× |
| Q4 FY18 | 26 May 2018 | +5.1% | -6.8% | +4.2% | 1.3× |
| Q3 FY18 | 16 Mar 2018 | +2.2% | -1.2% | -0.3% | 1.4× |
| Q2 FY18 | 1 Nov 2017 | -0.9% | -2.6% | +13.9% | 1.1× |
| Q1 FY18 | 21 Aug 2017 | -4.3% | -0.8% | -0.7% | 1.9× |
| Q4 FY17 | 15 May 2017 | 0.0% | +2.6% | -5.4% | 0.4× |
| Q3 FY17 | 25 Jan 2017 | +1.2% | +0.9% | +1.6% | 1.2× |
| Q2 FY17 | 4 Nov 2016 | +2.1% | -9.3% | 0.0% | 2.1× |
| Q1 FY17 | 29 Sept 2016 | +0.1% | -2.0% | -0.3% | 0.5× |
| Q4 FY16 | 29 Apr 2016 | -0.6% | +2.0% | +1.6% | 0.8× |
| Q3 FY16 | 3 Feb 2016 | +0.1% | +0.9% | +5.3% | 1.5× |
| Q1 FY16 | 19 Nov 2015 | -0.5% | -1.4% | -4.6% | 0.7× |
| Q2 FY16 | 2 Nov 2015 | +0.7% | -7.1% | -11.1% | 0.5× |
| Q4 FY15 | 19 May 2015 | +1.7% | +10.2% | +6.6% | 0.9× |
| Q3 FY15 | 5 Feb 2015 | -1.0% | +2.3% | +21.7% | 0.3× |
| Q2 FY15 | 3 Nov 2014 | -1.6% | +13.0% | +34.2% | 0.9× |
| Q1 FY15 | 11 Aug 2014 | -1.7% | +5.5% | +12.0% | 0.3× |
| Q4 FY14 | 8 May 2014 | -4.5% | -3.7% | +9.7% | 0.8× |
| Q3 FY14 | 29 Jan 2014 | -1.3% | +0.6% | +10.4% | 0.7× |
| Q2 FY14 | 6 Nov 2013 | +1.0% | +5.3% | +2.2% | 0.6× |
| Q1 FY14 | 2 Aug 2013 | -3.0% | -3.6% | -3.7% | 0.3× |
| Q4 FY13 | 21 May 2013 | +5.3% | +1.5% | -1.9% | 1.6× |
| Q3 FY13 | 23 Jan 2013 | +20.0% | +54.7% | +46.6% | 36.5× |
| Q2 FY13 | 30 Oct 2012 | -3.7% | -6.3% | -8.7% | 1.2× |
| Q1 FY13 | 19 Jul 2012 | +2.1% | +0.6% | +9.1% | 4.5× |
| Q4 FY12 | 3 May 2012 | +1.2% | +2.0% | +13.3% | 0.5× |
| Q3 FY12 | 24 Jan 2012 | +6.8% | +7.5% | +28.0% | 7.7× |
| Q2 FY12 | 24 Oct 2011 | -0.5% | +2.9% | -0.5% | 1.5× |
| Q1 FY12 | 29 Jul 2011 | -0.8% | -12.5% | -13.6% | 0.7× |
| Q4 FY11 | 30 Apr 2011 | +3.1% | -0.4% | +9.6% | 3.0× |
| Q3 FY11 | 20 Jan 2011 | +19.2% | +12.8% | +7.3% | 65.3× |
| Q2 FY11 | 22 Oct 2010 | +0.9% | -5.1% | -11.0% | 3.2× |
| Q1 FY11 | 30 Jul 2010 | +2.4% | -1.3% | +16.6% | 1.0× |
| Q4 FY10 | 6 May 2010 | +0.3% | -4.6% | -2.0% | 1.0× |
| Q3 FY10 | 29 Jan 2010 | -0.4% | -0.4% | +4.1% | 0.3× |
| Q2 FY10 | 29 Oct 2009 | -3.5% | -3.5% | 0.0% | 1.6× |
| Q1 FY10 | 30 Jul 2009 | 0.0% | -3.2% | +3.8% | 0.6× |
| Q4 FY09 | 15 May 2009 | +17.0% | +42.0% | +33.0% | 0.0× |
| Q3 FY09 | 30 Jan 2009 | 0.0% | +4.3% | -3.3% | 0.3× |
| Q2 FY09 | 23 Oct 2008 | +2.0% | +1.0% | -8.1% | 1.8× |
| Q1 FY09 | 30 Jul 2008 | +3.5% | +3.5% | 0.0% | 2.1× |
| Q4 FY08 | 30 Apr 2008 | +5.5% | +9.2% | +1.2% | 3.1× |
| Q3 FY08 | 30 Jan 2008 | +5.6% | +7.7% | +5.6% | 0.8× |
| Q2 FY08 | 30 Oct 2007 | -0.6% | -4.3% | -0.6% | 0.5× |
| Q1 FY08 | 30 Jul 2007 | -4.7% | -8.9% | -11.1% | 0.4× |
| Q4 FY07 | 27 Apr 2007 | +6.8% | +9.1% | +11.4% | 8.4× |
| Average | +1.9% | +2.7% | +4.0% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q2 FY27
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +17.7% | +16.8% | +14.7% | +14.6% | +14.8% | +15.6% |
| Profit | +20.1% | +24.1% | +17.0% | +12.4% | +14.7% | +18.4% |
Key data
Delivery percentage
Over the last 20 sessions AJANTPHARM settled 55.2% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 53.6%. The latest session ranks higher than 81% of the 3,629 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Dividends, deals & holders
Performance returns
| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +1.45% | +1.03% | +1.44% | -9.32% | +5.35% | +31.49% |
Valuation
Ownership
Quarterly results · consolidated
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 1,374.8 | 1,421.6 | 1,626.0 | 1,794.2 |
| YoY chg | +20.0% | +21.5% | +24.8% | +32.5% |
| Net profit (₹ Cr) | 273.8 | 266.7 | 334.2 | 388.1 |
| YoY chg | +17.6% | +18.4% | +30.9% | +49.2% |
| Net margin | 19.9% | 18.8% | 20.6% | 21.6% |
| EPS | 21.91 | 21.34 | 26.72 | 31.03 |
Shareholding over time
By quarter
30 Sept 2026 · promoter 63.47% · public 36.53%- Promoter
- Public and others
- Promoter
- 63.47%
- Public
- 36.53%
- Promoter change
- -0.01 pp
- Filed
- 13 Oct 2026
- FII
- 7.63%
- DII
- 21.94%
- Promoter pledged
- 20.65%
Who the public is
- Mutual funds
- 17.95%
- Insurance
- 3.58%
- FPI
- 7.62%
- Retail ≤ ₹2L
- 5.57%
- HNI > ₹2L
- 0.64%
- NRI
- 0.29%
- Bodies corporate
- 0.18%
- Shareholders
- 61,923
-0.15 pp QoQ
+0.29 pp QoQ
-0.06 pp QoQ
-0.14 pp QoQ
+0.09 pp QoQ
-0.01 pp QoQ
+0.01 pp QoQ
-5.2% QoQ
Major holders
As of 30 Sept 2026| Holder | Type | Holding | Shares |
|---|---|---|---|
| Rajesh M Agrawal, trustee Rajesh Agrawal Trust | Promoter · Individual | 14.47% | 1.81Cr |
| Yogesh M Agrawal, trustee Yogesh Agrawal Trust | Promoter · Individual | 14.47% | 1.81Cr |
| Aayush M Agrawal, trustee Aayush Agrawal Trust | Promoter · Individual | 11.29% | 1.41Cr |
| Ravi P Agrawal, trustee Ravi Agrawal Trust | Promoter · Individual | 10.24% | 1.28Cr |
| Gabs Investments Pvt Ltd | Promoter · Corporate | 10.07% | 1.26Cr |
| Kotak Flexicap Fund | Mutual fund | 3.22% | 40.27L |
| Uti-Flexi Cap Fund | Mutual fund | 2.97% | 37.17L |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | Mutual fund | 2.79% | 34.86L |
| Ganga Exports being represented by Yogesh Agrawal, Rajesh Agrawal & Ravi Agrawal | Promoter · Individual | 2.68% | 33.48L |
| Aditya Birla Sun Life Mutual Fund - Aditya Birla Sun Life Midcap Fund | Mutual fund | 2.22% | 27.71L |
Every promoter-group member, and each public holder above 1%, as filed.
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.
Dividends
| Financial year | Payments | Declared | Adjusted |
|---|---|---|---|
| FY2026-27 | 1 | ₹32.00 | ₹32.00 |
| FY2025-26 | 1 | ₹28.00 | ₹28.00 |
| FY2024-25 | 1 | ₹28.00 | ₹28.00 |
| FY2023-24 | 2 | ₹51.00 | ₹51.00 |
| FY2022-23 | 1 | ₹7.00 | ₹7.00 |
| FY2021-22 | 1 | ₹9.50 | ₹6.33 |
| FY2020-21 | 1 | ₹9.50 | ₹6.33 |
| FY2019-20 | 1 | ₹13.00 | ₹8.67 |
| FY2018-19 | 1 | ₹9.00 | ₹6.00 |
| FY2016-17 | 2 | ₹13.00 | ₹8.67 |
| FY2015-16 | 2 | ₹14.00 | ₹9.33 |
| FY2014-15 | 1 | ₹10.00 | ₹2.67 |
| FY2013-14 | 1 | ₹6.25 | ₹1.11 |
| FY2012-13 | 1 | ₹7.50 | ₹0.67 |
| Ex-date | Record date | Declared | Adjusted |
|---|---|---|---|
| 5 Aug 2026 | — | ₹32.00 | ₹32.00 |
| 10 Nov 2025 | — | ₹28.00 | ₹28.00 |
| 6 Nov 2024 | — | ₹28.00 | ₹28.00 |
| 8 Feb 2024 | — | ₹26.00 | ₹26.00 |
| 4 Aug 2023 | — | ₹25.00 | ₹25.00 |
| 11 Nov 2022 | — | ₹7.00 | ₹7.00 |
| 9 Nov 2021 | — | ₹9.50 | ₹6.33 |
| 12 Nov 2020 | — | ₹9.50 | ₹6.33 |
| 15 Nov 2019 | — | ₹13.00 | ₹8.67 |
| 9 Nov 2018 | — | ₹9.00 | ₹6.00 |
| 23 Mar 2017 | — | ₹7.00 | ₹4.67 |
| 7 Nov 2016 | — | ₹6.00 | ₹4.00 |
| 17 Mar 2016 | — | ₹8.00 | ₹5.33 |
| 25 Jun 2015 | — | ₹6.00 | ₹4.00 |
| 24 Jul 2014 | — | ₹10.00 | ₹2.67 |
| 18 Jul 2013 | — | ₹6.25 | ₹1.11 |
| 28 Jun 2012 | — | ₹7.50 | ₹0.67 |
Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.
52-week highs & lows
Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.
Book closures & record dates
NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.
Insider trades
- Insiders net, 30d
- ₹0
- Insiders net, 90d
- ₹0
- Promoters net, 90d
- ₹0
- Insider buyers, 90d
- 0
- Last promoter buy
- none on record
- Disclosures on record
- 412
| Broadcast | Person | Side | Shares | Value | Price | Holding before → after | Stake | Regulation |
|---|---|---|---|---|---|---|---|---|
| 29 Jun 2026 | A V JAYAKUMAREmployee | Sell | 2.5K | ₹81.8L | 3,271.00 | 6.3K → 3.8K | 0.00%0.00 pp | 7(2)told 29 Jun 2026 |
| 29 Jun 2026 | JAGDISH DWARKADAS JOSHIEmployee | Sell | 725 | ₹24.1L | 3,329.00 | 7.5K → 6.8K | 0.01%-0.00 pp | 7(2)told 29 Jun 2026 |
| 9 Jun 2026 | RAVI P AGRAWAL, TRUSTEE RAVI AGRAWAL TRUSTPromoter | Sell | 34.50L | ₹1,024.0Cr | 2,968.00 | 1.62Cr → 1.28Cr | 10.24%-2.76 pp | 7(2)told 9 Jun 2026 |
| 13 Mar 2026 | SHAILESH R SINGHOther | Sell | 607 | ₹18.8L | 3,100.18 | 14.1K → 13.5K | 0.01%-0.00 pp | 7(2)told 13 Mar 2026 |
| 29 Dec 2025 | SHAILESH R SINGHOther | Sell | 750 | ₹20.3L | 2,713.08 | 14.9K → 14.1K | 0.01%-0.00 pp | 7(2)told 29 Dec 2025 |
| 13 Nov 2025 | SHAILESH R SINGHOther | Sell | 2.0K | ₹51.3L | 2,565.41 | 16.9K → 14.9K | 0.01%-0.00 pp | 7(2)told 13 Nov 2025 |
| 13 Nov 2025 | SHAILESH R SINGHOther | Sell | 3.0K | ₹75.9L | 2,528.43 | 19.9K → 16.9K | 0.01%-0.00 pp | 7(2)told 13 Nov 2025 |
| 26 Jun 2025 | SHAILESH R SINGHOther | Sell | 900 | ₹23.2L | 2,574.43 | 19.8K → 18.9K | 0.02%-0.00 pp | 7(2)told 26 Jun 2025 |
| 28 Feb 2025 | VANDANA SHAILESH SINGHOther | Sell | 548 | ₹14.9L | 2,722.45 | 548 → — | 0.00% | 7(2)told 27 Feb 2025 |
| 31 Dec 2024 | J K TRIPATHIOther | Sell | 100 | ₹3.0L | 2,950.00 | 700 → 600 | 0.00%0.00 pp | 7(2)told 31 Dec 2024 |
| 31 Dec 2024 | J K TRIPATHIOther | Sell | 100 | ₹2.9L | 2,895.00 | 800 → 700 | 0.00%0.00 pp | 7(2)told 31 Dec 2024 |
| 31 Dec 2024 | J K TRIPATHIOther | Sell | 100 | ₹3.0L | 3,000.00 | 900 → 800 | 0.00%0.00 pp | 7(2)told 31 Dec 2024 |
| 31 Dec 2024 | J K TRIPATHIOther | Sell | 49 | ₹1.5L | 3,060.00 | 949 → 900 | 0.00%0.00 pp | 7(2)told 31 Dec 2024 |
| 31 Dec 2024 | J K TRIPATHIOther | Sell | 51 | ₹1.6L | 3,100.00 | 1.0K → 949 | 0.00%0.00 pp | 7(2)told 31 Dec 2024 |
| 6 Sept 2024 | SEEMA AGRAWALRelative | Sell | 5.0K | ₹1.6Cr | 3,287.23 | 26.0K → 21.0K | 0.02%-0.00 pp | 7(2)told 6 Sept 2024 |
| 6 Sept 2024 | ARVIND K AGRAWALOther | Sell | 6.0K | ₹2.0Cr | 3,293.62 | 23.3K → 17.3K | 0.01%-0.00 pp | 7(2)told 6 Sept 2024 |
| 4 Sept 2024 | J K TRIPATHIOther | Sell | 100 | ₹3.2L | 3,200.00 | 1.1K → 1.0K | 0.00%0.00 pp | 7(2)told 4 Sept 2024 |
| 4 Sept 2024 | J K TRIPATHIOther | Sell | 100 | ₹3.0L | 2,991.03 | 1.2K → 1.1K | 0.00%0.00 pp | 7(2)told 4 Sept 2024 |
| 4 Sept 2024 | J K TRIPATHIOther | Sell | 200 | ₹5.6L | 2,808.53 | 900 → 700 | 0.00%0.00 pp | 7(2)told 4 Sept 2024 |
| 9 Aug 2024 | JAGDISH DWARKADAS JOSHIOther | Sell | 2.0K | ₹59.0L | 2,952.46 | 8.8K → 6.8K | 0.01%-0.00 pp | 7(2)told 9 Aug 2024 |
| 14 Jun 2024 | SHAILESH R SINGHOther | Sell | 1.2K | ₹29.0L | 2,416.33 | 20.1K → 18.9K | 0.02%-0.00 pp | 7(2)told 12 Jun 2024 |
| 14 Jun 2024 | SHAILESH R SINGHOther | Sell | 1.8K | ₹43.6L | 2,423.54 | 21.9K → 20.1K | 0.02%-0.00 pp | 7(2)told 12 Jun 2024 |
| 16 Feb 2024 | JAGDISH DWARKADAS JOSHIOther | Sell | 1.0K | ₹21.5L | 2,151.35 | 9.0K → 8.0K | 0.01%-0.00 pp | 7(2)told 15 Feb 2024 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 20 | ₹38,721 | 1,936.05 | 505 → 525 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 30 | ₹55,539 | 1,851.30 | 475 → 505 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 5 | ₹9,415 | 1,883.00 | 470 → 475 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 5 | ₹9,400 | 1,880.00 | 465 → 470 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 5 | ₹9,395 | 1,879.00 | 460 → 465 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 5 | ₹9,380 | 1,876.00 | 455 → 460 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 5 | ₹9,390 | 1,878.00 | 450 → 455 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 25 | ₹46,625 | 1,865.00 | 425 → 450 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 50 | ₹90,433 | 1,808.66 | 375 → 425 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 25 | ₹45,141 | 1,805.64 | 350 → 375 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 125 | ₹2.3L | 1,823.05 | 225 → 350 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 27 | ₹49,319 | 1,826.63 | 198 → 225 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 50 | ₹94,017 | 1,880.34 | 650 → 700 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 50 | ₹93,750 | 1,875.00 | 600 → 650 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 50 | ₹94,545 | 1,890.90 | 550 → 600 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 25 | ₹48,778 | 1,951.12 | 525 → 550 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 21 Dec 2023 | J K TRIPATHIOther | Buy | 70 | ₹1.3L | 1,833.53 | 128 → 198 | 0.00%0.00 pp | 7(2)told 19 Dec 2023 |
| 20 Dec 2023 | JAGDISH DWARKADAS JOSHIOther | Sell | 926 | ₹17.5L | 1,892.00 | 10.2K → 9.3K | 0.01%-0.00 pp | 7(2)told 20 Dec 2023 |
| 12 Jun 2023 | Satish AgrawalEmployee | Sell | 1.1K | ₹16.5L | 1,498.34 | 93.0K → 91.9K | 0.07%-0.00 pp | 7(2)told 8 Jun 2023 |
| 9 Jun 2023 | MATHEW PAUL EDELSONOther | Sell | 1.5K | ₹20.6L | 1,370.94 | 1.5K → — | 0.00% | 7(2)told 7 Jun 2023 |
| 29 May 2023 | JOHN GERARD ADAMSOther | Sell | 8.3K | ₹1.0Cr | 1,257.51 | 8.3K → — | 0.00% | 7(2)told 29 May 2023 |
| 25 May 2023 | JEFFREY WILLIAM BURDOther | Sell | 2.3K | ₹28.8L | 1,279.35 | 2.3K → — | 0.00% | 7(2)told 24 May 2023 |
| 22 May 2023 | Dr. Shailesh SinghOther | Sell | 1.1K | ₹13.8L | 1,289.20 | 23.0K → 21.9K | 0.02%-0.00 pp | 7(2)told 22 May 2023 |
SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.
How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session
Filings
CSVBulk & block deals · 9 Jun 2026
CSV| Date | Deal | Client | Quantity | Price | Value |
|---|---|---|---|---|---|
| 9 Jun 2026 | Sell · block, also bulk | RAVI AGRAWAL TRUST | 34.50L | 2,968.00 | ₹1,024.0Cr |
| 9 Jun 2026 | Buy · block, also bulk | KOTAK MAHINDRA MUTUAL FUND | 21.02L | 2,968.00 | ₹624.0Cr |
| 9 Jun 2026 | Buy · block | ADITYA BIRLA SUN LIFE MUTUAL FUND | 13.48L | 2,968.00 | ₹400.0Cr |
| 22 Dec 2022 | Sell · block, also bulk | AAYUSH AGRAWAL TRUST | 38.54L | 1,160.10 | ₹447.1Cr |
| 22 Dec 2022 | Sell · block, also bulk | RAVI AGRAWAL TRUST | 16.39L | 1,160.10 | ₹190.1Cr |
| 22 Dec 2022 | Buy · block, also bulk | ICICI PRUDENTIAL MUTUAL FUND | 10.86L | 1,160.10 | ₹126.0Cr |
| 22 Dec 2022 | Buy · block, also bulk | NIPPON INDIA MUTUAL FUND | 7.15L | 1,160.10 | ₹83.0Cr |
| 22 Dec 2022 | Buy · block | ADITYA BIRLA SUN LIFE MUTUAL FUND | 5.01L | 1,160.10 | ₹58.1Cr |
| 22 Dec 2022 | Buy · block | GRANDEUR PEAK INTERNATIONAL STALWARTS FUND | 4.42L | 1,160.10 | ₹51.3Cr |
| 22 Dec 2022 | Buy · block | FRANKLIN TEMPLETON INVESTMENT FUNDS - TEMPLETON ASIAN SMALLER COMPANIES FUND | 3.44L | 1,160.10 | ₹39.9Cr |
| 22 Dec 2022 | Buy · block | TATA AIA LIFE INSURANCE COMPANY LIMITED | 3.23L | 1,160.10 | ₹37.5Cr |
| 22 Dec 2022 | Buy · block | UTI MUTUAL FUND | 3.05L | 1,160.10 | ₹35.3Cr |
A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.
Takeover-code disclosures
Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.
Every stock on this session →Short selling, lending & margin
Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.
Exchange surveillance
No surveillance measure applies to AJANTPHARM.
Price band: 20% · not in the F&O ban · 3.7% of the market-wide position limit used.
From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: band changes · MWPL.
Every stock on this session →Futures & options · 27 Jun 2019
CSVLong unwinding — price down as positions closed — longs exiting.
- Futures OI
- 51.0K
- OI change
- -72.02%
- Basis
- -0.15%
- Rollover
- 0.0%
- PCR (OI)
- 0.53
- PCR (volume)
- 1.03
- Front settle
- 956.10
- Lot size
- —
- Futures volume
- 450
- Futures trades
- —
- Futures value
- ₹21.4Cr
- Sessions shown
- 250
₹3.3Cr
shares
contracts
Open interest is in shares (index units for an index), summed over every expiry; volume, trades and traded value too. Settle and lot size are the front future’s. Buildup compares the close’s direction with the change in futures OI across the contracts still open, so an expiring contract does not read as unwinding. Scan it with pattern is long_buildup.
Financials · quarterly statement
| Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Q2 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 1,105.2 | 1,054.1 | 1,144.9 | 1,186.6 | 1,146.1 | 1,170.4 | 1,302.7 | 1,353.7 | 1,374.8 | 1,421.6 | 1,626.0 | 1,794.2 | |
| Other income | 13.6 | 35.5 | 26.5 | 19.5 | 30.4 | 18.1 | 26.3 | 59.3 | 25.0 | 61.4 | 70.9 | 37.4 | |
| Total income | 1,118.7 | 1,089.6 | 1,171.4 | 1,206.1 | 1,176.6 | 1,188.5 | 1,329.0 | 1,413.1 | 1,399.8 | 1,483.1 | 1,696.9 | 1,831.6 | |
| Total expenses | 827.8 | 811.5 | 849.3 | 915.9 | 869.2 | 919.1 | 997.9 | 1,072.3 | 1,041.2 | 1,136.0 | 1,250.1 | 1,296.4 | |
| └ Finance costs | 2.5 | 1.5 | 0.7 | 6.0 | 7.9 | 6.1 | 5.3 | 3.4 | 5.1 | 2.4 | 3.2 | 2.2 | |
| └ Depreciation | 34.3 | 34.3 | 34.0 | 34.4 | 36.0 | 39.8 | 41.3 | 43.0 | 43.5 | 45.4 | 44.5 | 47.6 | |
| Profit before tax | 290.9 | 278.0 | 322.1 | 290.2 | 307.4 | 269.4 | 331.1 | 340.8 | 358.6 | 347.1 | 446.8 | 535.2 | |
| Tax expense | 80.9 | 75.3 | 76.4 | 73.8 | 74.5 | 44.2 | 75.8 | 80.6 | 84.8 | 80.4 | 112.6 | 147.0 | |
| Net profit | 210.0 | 202.7 | 245.8 | 216.5 | 232.9 | 225.3 | 255.3 | 260.2 | 273.8 | 266.7 | 334.2 | 388.1 | |
| EPS | 16.68 | 16.10 | 19.54 | 17.27 | 18.60 | 18.00 | 20.44 | 20.83 | 21.91 | 21.35 | 26.75 | 31.07 | |
| Net margin | 19.00% | 19.23% | 21.47% | 18.24% | 20.32% | 19.25% | 19.60% | 19.22% | 19.91% | 18.76% | 20.56% | 21.63% | |
| PBT margin | 26.32% | 26.38% | 28.13% | 24.46% | 26.82% | 23.02% | 25.42% | 25.18% | 26.08% | 24.42% | 27.48% | 29.83% | |
| Tax rate | 27.80% | 27.09% | 23.70% | 25.41% | 24.24% | 16.39% | 22.89% | 23.66% | 23.66% | 23.17% | 25.20% | 27.47% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 30 Oct 2026.
Balance sheet & cash flow · half-yearly
Balance sheet
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4,679.0 | 4,433.2 | 4,638.4 | 4,790.5 | 5,015.0 | 5,672.4 | 6,154.8 | 6,425.3 | |
| Current assets | 2,825.2 | 2,562.8 | 2,722.1 | 2,785.9 | 2,829.7 | 3,393.6 | 3,735.4 | 3,823.3 | |
| └ Cash & equivalents | 329.8 | 261.8 | 129.5 | 63.9 | 175.1 | 89.8 | 103.3 | 90.2 | |
| └ Other bank balances | 1.1 | 1.0 | 1.3 | 1.0 | 1.1 | 1.3 | 1.5 | 1.8 | |
| └ Current investments | 510.3 | 212.8 | 330.1 | 677.0 | 438.7 | 849.0 | 559.9 | 588.1 | |
| └ Trade receivables | 1,056.9 | 1,141.4 | 1,246.8 | 1,016.4 | 1,182.7 | 1,447.5 | 1,853.9 | 1,863.6 | |
| └ Inventories | 815.6 | 785.8 | 828.4 | 845.7 | 903.9 | 812.1 | 938.5 | 966.6 | |
| Total equity | 3,388.0 | 3,481.9 | 3,567.4 | 3,677.0 | 3,790.3 | 4,315.0 | 4,527.1 | 4,858.3 | |
| └ Attributable to owners | 3,388.0 | 3,481.9 | 3,567.4 | 3,677.0 | 3,790.3 | 4,315.0 | 4,527.1 | 4,858.3 | |
| └ Non-controlling interest | 0.0 | 0.0 | 0.0 | 0.0 | — | 0.0 | 0.0 | 0.0 | |
| └ Share capital | 25.3 | 25.3 | 25.3 | 25.1 | 25.1 | 25.1 | 25.1 | 25.1 | |
| Borrowings | 1.4 | 0.9 | 1.5 | 2.4 | 2.6 | 201.7 | 212.0 | 104.3 | |
| └ Current | 0.2 | 0.9 | 1.5 | 0.0 | 2.6 | 201.7 | 212.0 | 104.3 | |
| └ Non-current | 1.3 | 0.0 | 0.0 | 2.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Trade payables | 422.8 | 361.1 | 463.2 | 420.9 | 454.2 | 430.1 | 544.3 | 571.2 | |
| Current liabilities | 1,139.3 | 799.3 | 895.3 | 536.9 | 996.1 | 1,159.8 | 1,415.8 | 1,342.8 | |
| Total liabilities | 1,291.0 | 951.4 | 1,071.0 | 1,113.6 | 1,224.7 | 1,357.4 | 1,627.8 | 1,567.0 | |
| Net debt | (839.7) | (474.7) | (459.3) | (739.5) | (612.4) | (738.4) | (452.6) | (575.7) | |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.05 | 0.02 | |
| Current ratio | 2.48 | 3.21 | 3.04 | 5.19 | 2.84 | 2.93 | 2.64 | 2.85 |
Cash flow, year to date
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 791.8 | 399.0 | 785.1 | 776.5 | 1,157.2 | 283.9 | 529.2 | 749.5 | |
| └ Capex | (174.5) | (61.2) | (152.4) | (149.7) | (317.9) | (173.5) | (365.2) | (259.0) | |
| Free cash flow | 617.3 | 337.9 | 632.7 | 626.7 | 839.3 | 110.5 | 164.0 | 490.5 | |
| Investing cash flow | (559.6) | 245.9 | 65.4 | (475.7) | (376.5) | (548.9) | (428.9) | (249.1) | |
| Financing cash flow | (107.9) | (713.7) | (1,051.1) | (366.0) | (733.4) | 181.5 | (167.9) | (514.7) | |
| └ Dividends paid | (89.7) | (314.8) | (642.2) | 0.0 | (349.4) | (0.0) | (349.7) | (399.6) | |
| └ Buybacks | (1.4) | (389.2) | (389.2) | (353.6) | (353.0) | 0.0 | 0.0 | 0.0 | |
| Net change in cash | 123.5 | (68.0) | (200.3) | (65.6) | 45.6 | (85.3) | (67.7) | (14.3) |
From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.
Announcements & board meetings
As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.
Every stock on this session →AJANTPHARM at a glance
- AJANTPHARM closed at ₹3,317.7 on 20 Nov 2026, +1.45% on the day, +31.5% over one year, 12.6% below its 52-week high of ₹3,796.
- Delivery was 57.7% of traded quantity on 20 Nov 2026, the 81st percentile of its own 3,629 sessions with a reading (20-session average 55.2%, 1-year average 53.6%).
- Market capitalisation is ₹41,458 crore at a trailing P/E of 32.8 (trailing EPS ₹101.06).
- Q2 FY27 results (consolidated, filed 30 Oct 2026): revenue ₹1,794 crore (+32.5% year on year), net profit ₹388 crore (+49.2%); the price moved +1.4% on the first session after.
- Promoters held 63.47% at 30 Sept 2026, down 0.01 percentage points on the previous filing, with 20.65% of promoter shares pledged.
- Q3 FY27 results are expected between 30 Jan 2027 and 2 Feb 2027, going by past filing dates — an estimate, not an announcement.
About
Sector history
- to 16 Aug 2026Index industry · Healthcare
- from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
NSE’s own classification, by the snapshot it changed on.
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.
More in Pharmaceuticals & Biotechnology
- DIDIVISLABDivi's Laboratories Limited11,180.50+0.02%
- LALAURUSLABSLaurus Labs Limited2,294.60-0.49%
- SUSUNPHARMASun Pharmaceutical Industries Limited1,884.90-0.79%
- ACACUTAASAcutaas Chemicals Limited3,833.50-3.61%
- SASAILIFESai Life Sciences Limited1,800.70+0.69%
- PPPPLPHARMAPiramal Pharma Limited239.30-0.15%
- DRDRREDDYDr. Reddy's Laboratories Limited1,390.20-0.76%
- GLGLENMARKGlenmark Pharmaceuticals Limited2,648.00+1.51%
- AUAUROPHARMAAurobindo Pharma Limited1,799.00-0.37%
- CICIPLACipla Limited1,415.00-0.25%
- ZYZYDUSLIFEZydus Lifesciences Limited1,200.00-0.24%
- MAMANKINDMankind Pharma Limited2,665.00+1.37%
All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE